Abdominal Binder Improves Lung Volumes and Voice in People With Tetraplegic Spinal Cord Injury

被引:22
作者
Wadsworth, Brooke M. [1 ,2 ]
Haines, Terry P. [3 ,4 ]
Cornwell, Petrea L. [5 ,6 ]
Rodwell, Leanne T. [7 ]
Paratz, Jennifer D. [8 ]
机构
[1] Princess Alexandra Hosp, Physiotherapy Dept, Woolloongabba, Qld 4102, Australia
[2] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia
[3] Monash Univ, Sch Primary Hlth Care, Physiotherapy Dept, Melbourne, Vic 3004, Australia
[4] Southern Hlth, Melbourne, Vic, Australia
[5] Metro N Hlth Serv Dist, Brisbane, Qld, Australia
[6] Griffith Univ, Griffith Hlth Inst, Brisbane, Qld 4111, Australia
[7] Royal Childrens Hosp, Resp Dept, Brisbane, Qld, Australia
[8] Univ Queensland, Sch Med, Burns Trauma & Crit Care Res Ctr, Brisbane, Qld, Australia
来源
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION | 2012年 / 93卷 / 12期
关键词
Orthostatic hypotension; Pulmonary function; Rehabilitation; Respiration; Speech; Spinal cord injuries; ORTHOSTATIC HYPOTENSION; SPEECH; INDIVIDUALS; MANAGEMENT; COUGH; MEN;
D O I
10.1016/j.apmr.2012.06.010
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Abdominal binder improves lung volumes and voice in people with tetraplegic spinal cord injury. Arch Phys Med Rehabil 2012;93:2189-97. Objective: To investigate the effect of an elasticated abdominal binder on respiratory, voice, and blood pressure outcomes for people with a motor complete acute tetraplegia during the first year after injury. Design: Randomized crossover study. Setting: Large university-affiliated referral hospital. Participants: Consenting participants (N=14, 13 men and 1 woman) with recent, motor complete, C3-T1 spinal cord injury. Interventions: Abdominal binder on/off with participant seated in upright wheelchair, with 3 repeated measures at 6 weeks, 3 months, and 6 months after commencing daily use of an upright wheelchair. Main Outcome Measures: Forced vital capacity, forced expiratory volume in 1 second, peak expiratory flow, maximal inspiratory pressure, and maximal expiratory pressure were measured. Mean arterial pressure, maximum sustained vowel time, and sound pressure level were also measured. Results: Overall, an abdominal binder resulted in a statistically significant improvement in forced vital capacity (weighted mean difference .34L [95% confidence interval (CI).10-.58], P=.005), forced expiratory volume in 1 second (.25L [95% CI -.01 to .51], P=.05), peak expiratory flow (.81L/s [95% CI .13-1.48], P=.02), maximal inspiratory pressure (7.40cmH(2)O [95% CI 1.64-13.14], P=.01), and maximum sustained vowel time (3.75s [95% CI .90-6.60], P=.01). There was no statistically significant improvement in maximal expiratory pressure (5.37cmH(2)O [95% CI -1.15 to 11.90], P=.11), mean arterial pressure (4.41mmHg [95% CI -6.15 to 14.97], P=.41), or sound pressure level (1.14dB [95% CI -1.31 to 3.58], P=.36). Conclusions: An individually fitted abdominal binder significantly improved forced vital capacity, forced expiratory volume in I second, peak expiratory flow, maximal inspiratory pressure, and maximum sustained vowel time in people with newly acquired tetraplegia. Further study is needed into the effect of the long-term use of the abdominal binder on breathing mechanics, functional residual capacity, total lung capacity, and respiratory health.
引用
收藏
页码:2189 / 2197
页数:9
相关论文
共 43 条
[1]  
AIHW: Norton L, 2010, INJ RES STAT SER
[2]   Electrophysiologic techniques for the assessment of respiratory muscle function [J].
Aldrich, TK ;
Sinderby, C ;
McKenzie, DK ;
Estenne, M ;
Gandevia, SC .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (04) :548-+
[3]  
ANKE A, 1993, SCAND J REHABIL MED, V25, P73
[4]  
Ashba J, 1993, J Am Paraplegia Soc, V16, P197
[5]  
Blackmer J, 1997, J Spinal Cord Med, V20, P212
[6]  
BOAVENTURA CM, 2003, PHYSIOTHERAPY, V89, P290
[7]  
Bravo Guadalupe, 2004, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V2, P133, DOI 10.2174/1568016043477242
[8]  
Brown R, 2006, RESP CARE, V51, P853
[9]  
Buchanan L, 1987, SPINAL CORD INJURY C, P72
[10]   Outcomes for COPD pharmacological trials:: from lung function to biomarkers [J].
Cazzola, M. ;
MacNee, W. ;
Martinez, F. J. ;
Rabe, K. F. ;
Franciosi, L. G. ;
Barnes, P. J. ;
Brusasco, V. ;
Burge, P. S. ;
Calverley, P. M. A. ;
Celli, B. R. ;
Jones, P. W. ;
Mahler, D. A. ;
Make, B. ;
Miravitlles, M. ;
Page, C. P. ;
Palange, P. ;
Parr, D. ;
Pistolesi, M. ;
Rennard, S. I. ;
Moelken, M. P. Rutten-Van ;
Stockley, R. ;
Sullivan, S. D. ;
Wedzicha, J. A. ;
Wouters, E. F. .
EUROPEAN RESPIRATORY JOURNAL, 2008, 31 (02) :416-468